by Ross Camidge | May 14, 2020 | Featured, Patient Care
D. Ross Camidge, MD, PhD, director of thoracic oncology and the Joyce Zeff Chair in Lung Cancer Research at the University of Colorado Cancer Center March 5th: The first confirmed case of COVID-19 in Colorado is reported in a young man who had been on vacation to...
by Garth Sundem | Apr 28, 2020 | Featured, Latest News, Research
Emily Simons, MD, MPH An important goal of early-phase clinical trials is to discover a drug’s possible side effects. But despite FDA guidelines seeking to standardize this reporting, a University of Colorado Cancer Center study finds significant variation in how drug...
by Garth Sundem | Apr 22, 2020 | Featured, Latest News, Research
Tejas Patil, MD Tejas Patil, MD, is a medical oncologist. Lisa Ferrigno, MD, MPH, FACS, is a trauma surgeon. Working with lung cancer patients at University of Colorado Cancer Center, they both, independently, noticed something strange: A small percentage of patients...
by Garth Sundem | Mar 11, 2020 | Featured, Latest News
Rustain Morgan, MD, CU Cancer Center investigator and assistant professor in the CU School of Medicine Department of Radiology The use of PET-CT imaging gives doctors the best possible picture of non-small cell lung cancer (NSCLC), and this accurate imaging helps to...
by Garth Sundem | Dec 13, 2019 | Featured, Latest News
Robert C. Doebele, MD, PhD Pooled analysis of three phase 1 and 2 clinical trials published online ahead of print in the journal Lancet Oncology show that the drug entrectinib is effective and well-tolerated against advanced ROS1 and NTRK fusion-positive non-small...
